FXR inhibitor, Fexaramine, Purity ≥98%

Synonym: 574013-66-4; 3-[3-[(cyclohexylcarbonyl)[[4'-(dimethylamino)[1,1'-biphenyl]-4-yl]methyl]amino]phenyl]-2-propenoic acid, methyl ester; Fexaramine; 2-Propenoic acid, 3-[3-[(cyclohexylcarbonyl)[[4'-(dimethylamino)[1,1'-biphenyl]-4-yl]methyl]amino]phenyl]-, methyl ester; Methyl (E)-3-[3-[cyclohexanecarbonyl-[[4-[4-(dimethylamino)phenyl]phenyl]methyl]amino]phenyl]prop-2-enoate; FXR inhibitor

MDL: MFCD09971007
CAS Number: 574013-66-4
Compound CID: 5326713

Product Size

5 mg; 10 mg; 50 mg; 100 mg

Price

Datasheet

Datasheet

MSDS

MSDS

Properties

Description

Fexaramine, soluble in DMSO, is an effective metabolism inhibitor, that has the ability to prevent the pathway of cell metabolism by inhibiting FXR. The molecular weight of the compound is 496.64, and its molecular formula is C₃₂H₃₆N₂O₃.

Molecular Weight

496.64

Molecular Formula

C₃₂H₃₆N₂O₃

Form

Lyophilized powder

Purity

≥98%

Impurities

Free from inappropriate visible particulates, foreign matter, discoloration, or other defects.

Solubility

In vitro: DMSO: 89 mg/mL (179.2 mM)

Identity

Confirmed by NMR/HPLC/MS.

Applications

Fexaramine can be studied extensively for its potential therapeutic applications in the treatment of metabolic syndrome, including non-alcoholic fatty liver disease (NAFLD) and related conditions.